因为在辉瑞制药与百康制药的合作中显示，双方都可能需要合作伙伴。
As the Pfizer deal with Biocon suggests, both sides may need partners.
百康公司总裁基朗妈祖达尔-萧说非专利药品企业享受在制药业内享受的“简单取代策略”在复杂的生物仿制制药领域将不凑效了---在生物仿制制药领域，需要有医生的批准才可以进行。
Kiran Mazumdar-Shaw, head of Biocon, says the "easy substitution" that generics firms enjoy at the pharmacy does not work with complex biosimilars—which require a doctor's approval to dispense.
纽曼博士与康弗斯先生研发的新系统接入了世界各地几百所地震监测站。
The system Dr Newman and Mr Convers have developed taps into hundreds of seismic monitoring stations around the world.
应用推荐